SCHEMBL20710514

SCHEMBL20710514

COC(=O)Cc1ccc(CNc2nc(-c3cccnc3)nc3ccccc23)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 8/20 0.72
▸ CYP3A4 P08684 8/20 0.72
▸ CYP2D6 P10635 7/20 0.72
▸ MEN1 O00255 6/20 0.72
▸ KMT2A Q03164 6/20 0.72
▸ CYP2C19 P33261 6/20 0.72
▸ ALDH1A1 P00352 6/20 0.72
▸ TSHR P16473 6/20 0.72
▸ MAPK1 P28482 5/20 0.72
▸ HSD17B10 Q99714 5/20 0.72
▸ CLK4 Q9HAZ1 5/20 0.72
▸ LMNA P02545 5/20 0.72
▸ PDE5A O76074 4/20 0.72
▸ USP2 O75604 4/20 0.72
▸ TP53 P04637 2/20 0.72
▸ GBA1 P04062 2/20 0.72
▸ PTGS1 P23219 1/20 0.72
▸ TBXAS1 P24557 1/20 0.72
▸ PTGS2 P35354 1/20 0.72
▸ POLB P06746 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7276945 0.86 CYP1A2 (0.80) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL15289677 0.85 TSHR (0.77) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7286130 0.85 PDE5A (1.00) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7432190 0.82 MAPT (0.74) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7277274 0.81 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7280049 0.81 ALDH1A1 (0.80) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7280346 0.81 KMT2A (0.82) CYP1A2CYP3A4CYP2D6MEN1KMT2A
Hydrochloric Acid SCHEMBL7287894 0.81 ALDH1A1 (0.79) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7279569 0.81 PDE5A (0.77) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7411431 0.80 PDE5A (0.71) CYP1A2CYP3A4CYP2D6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200283444-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS AND USES THEREOF NORTHWESTERN UNIVERSITY 2020-09-10 — — US disclosed
WO-2019027765-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS AND USES THERE NORTHWESTERN UNIVERSITY (US) 2019-02-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200283444-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS AND USES THEREOF GBA3, GBA1, GBA2 CYP1A2 4410/4885CYP3A4 4190/4885CYP2D6 2479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback